Listed

Organogenesis Holdings Inc.

ORGONasdaqCIK 1661181HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$43.8m, Q2 FY2026
Operating income−$51.0m, Q2 FY2026
Net income−$96.3m, Q2 FY2026
Organogenesis Holdings Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m109Revenue, Q3 FY2023, three months to 2023-09-30$108.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure99.7Revenue, Q4 FY2023, three months to 2023-12-31$99.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure110Revenue, Q1 FY2024, three months to 2024-03-31$110.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure130Revenue, Q2 FY2024, three months to 2024-06-30$130.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure115Revenue, Q3 FY2024, three months to 2024-09-30$115.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure127Revenue, Q4 FY2024, three months to 2024-12-31$126.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure86.7Revenue, Q1 FY2025, three months to 2025-03-31$86.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure101Revenue, Q2 FY2025, three months to 2025-06-30$101.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure151Revenue, Q3 FY2025, three months to 2025-09-30$150.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure226Revenue, Q4 FY2025, three months to 2025-12-31$225.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure37.2Revenue, Q1 FY2026, three months to 2026-03-31$37.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure43.8Revenue, Q2 FY2026, three months to 2026-06-30$43.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Cost of revenue$m25.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$25.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure27.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$27.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-02-27, accession 0000950170-25-029137. Derived: 12-month figure less the 9-month figure.Report this figure28.7Cost of revenue, Q1 FY2024, three months to 2024-03-31$28.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure29.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$29.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure26.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$26.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure31.1Cost of revenue, Q4 FY2024, three months to 2024-12-31$31.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-02-27, accession 0000950170-25-029137. Derived: 12-month figure less the 9-month figure.Report this figure23.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$23.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figurenot reportednot reportednot reportednot reportednot reported
Gross profit$m82.7Gross profit, Q3 FY2023, three months to 2023-09-30$82.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure71.9Gross profit, Q4 FY2023, three months to 2023-12-31$71.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-27, accession 0000950170-25-029137. Derived: 12-month figure less the 9-month figure.Report this figure81.3Gross profit, Q1 FY2024, three months to 2024-03-31$81.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure101Gross profit, Q2 FY2024, three months to 2024-06-30$101.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure88.4Gross profit, Q3 FY2024, three months to 2024-09-30$88.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure95.6Gross profit, Q4 FY2024, three months to 2024-12-31$95.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-27, accession 0000950170-25-029137. Derived: 12-month figure less the 9-month figure.Report this figure63.0Gross profit, Q1 FY2025, three months to 2025-03-31$63.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figurenot reportednot reportednot reportednot reportednot reported
Research and development$m10.5Research and development, Q3 FY2023, three months to 2023-09-30$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure11.8Research and development, Q4 FY2023, three months to 2023-12-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure12.8Research and development, Q1 FY2024, three months to 2024-03-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure15.6Research and development, Q2 FY2024, three months to 2024-06-30$15.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure10.3Research and development, Q3 FY2024, three months to 2024-09-30$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure11.5Research and development, Q4 FY2024, three months to 2024-12-31$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure10.6Research and development, Q1 FY2025, three months to 2025-03-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure10.4Research and development, Q2 FY2025, three months to 2025-06-30$10.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure13.2Research and development, Q3 FY2025, three months to 2025-09-30$13.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure10.3Research and development, Q4 FY2025, three months to 2025-12-31$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure15.2Research and development, Q1 FY2026, three months to 2026-03-31$15.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure18.3Research and development, Q2 FY2026, three months to 2026-06-30$18.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Selling, general and administrative$m64.2Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$64.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure61.4Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$61.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure72.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$72.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure76.5Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$76.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure71.8Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$71.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure73.9Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$73.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure72.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$72.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure73.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$73.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure79.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$79.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure100Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$100.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure65.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$65.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure54.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$54.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Operating income$m8.1Operating income, Q3 FY2023, three months to 2023-09-30$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure(1.3)Operating income, Q4 FY2023, three months to 2023-12-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(3.9)Operating income, Q1 FY2024, three months to 2024-03-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure(13.9)Operating income, Q2 FY2024, three months to 2024-06-30−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure6.2Operating income, Q3 FY2024, three months to 2024-09-30$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure10.2Operating income, Q4 FY2024, three months to 2024-12-31$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(26.7)Operating income, Q1 FY2025, three months to 2025-03-31−$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(12.6)Operating income, Q2 FY2025, three months to 2025-06-30−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure20.7Operating income, Q3 FY2025, three months to 2025-09-30$20.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure63.3Operating income, Q4 FY2025, three months to 2025-12-31$63.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(68.9)Operating income, Q1 FY2026, three months to 2026-03-31−$68.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(51.0)Operating income, Q2 FY2026, three months to 2026-06-30−$51.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Interest expense$m0.4Interest expense, Q3 FY2023, three months to 2023-09-30$444.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure0.5Interest expense, Q4 FY2023, three months to 2023-12-31$502.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-29, accession 0000950170-24-023150. Derived: 12-month figure less the 9-month figure.Report this figure0.5Interest expense, Q1 FY2024, three months to 2024-03-31$514.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure0.6Interest expense, Q2 FY2024, three months to 2024-06-30$620.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure0.5Interest expense, Q3 FY2024, three months to 2024-09-30$471.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure(0.1)Interest expense, Q4 FY2024, three months to 2024-12-31−$61.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Interest expense, Q1 FY2025, three months to 2025-03-31−$961.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(0.7)Interest expense, Q2 FY2025, three months to 2025-06-30−$669.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure(0.4)Interest expense, Q3 FY2025, three months to 2025-09-30−$415.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure(0.2)Interest expense, Q4 FY2025, three months to 2025-12-31−$236.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(0.4)Interest expense, Q1 FY2026, three months to 2026-03-31−$380.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(0.1)Interest expense, Q2 FY2026, three months to 2026-06-30−$138.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Income tax$m4.5Income tax, Q3 FY2023, three months to 2023-09-30$4.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure(1.2)Income tax, Q4 FY2023, three months to 2023-12-31−$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(2.2)Income tax, Q1 FY2024, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure2.5Income tax, Q2 FY2024, three months to 2024-06-30$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure(6.5)Income tax, Q3 FY2024, three months to 2024-09-30−$6.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure2.6Income tax, Q4 FY2024, three months to 2024-12-31$2.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(6.9)Income tax, Q1 FY2025, three months to 2025-03-31−$6.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(2.4)Income tax, Q2 FY2025, three months to 2025-06-30−$2.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure(0.4)Income tax, Q3 FY2025, three months to 2025-09-30−$407.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure19.7Income tax, Q4 FY2025, three months to 2025-12-31$19.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(15.3)Income tax, Q1 FY2026, three months to 2026-03-31−$15.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure45.4Income tax, Q2 FY2026, three months to 2026-06-30$45.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Net income$m3.2Net income, Q3 FY2023, three months to 2023-09-30$3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure(0.6)Net income, Q4 FY2023, three months to 2023-12-31−$568.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(2.1)Net income, Q1 FY2024, three months to 2024-03-31−$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure(17.0)Net income, Q2 FY2024, three months to 2024-06-30−$17.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure12.3Net income, Q3 FY2024, three months to 2024-09-30$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure7.7Net income, Q4 FY2024, three months to 2024-12-31$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(18.8)Net income, Q1 FY2025, three months to 2025-03-31−$18.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(9.4)Net income, Q2 FY2025, three months to 2025-06-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure21.6Net income, Q3 FY2025, three months to 2025-09-30$21.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure43.7Net income, Q4 FY2025, three months to 2025-12-31$43.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(53.2)Net income, Q1 FY2026, three months to 2026-03-31−$53.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(96.3)Net income, Q2 FY2026, three months to 2026-06-30−$96.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Diluted EPS$ per share0.02Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure(0.13)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure0.09Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(0.10)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure0.11Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figurenot reported(0.44)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(0.77)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Basic EPS$ per share0.02Basic EPS, Q3 FY2023, three months to 2023-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figurenot reported(0.02)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure(0.13)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure0.09Basic EPS, Q3 FY2024, three months to 2024-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figurenot reported(0.17)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(0.10)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure0.11Basic EPS, Q3 FY2025, three months to 2025-09-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figurenot reported(0.44)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(0.77)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure

Balance sheet

Cash and equivalents$46.1m, Q2 FY2026
Long-term debt$62.3m, Q3 FY2024
Shareholders' equity$148.3m, Q2 FY2026
Organogenesis Holdings Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m98.2Cash and equivalents, Q3 FY2023, at 2023-09-30$98.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure104Cash and equivalents, FY2023, at 2023-12-31$103.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029137.Report this figure88.6Cash and equivalents, Q1 FY2024, at 2024-03-31$88.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure89.9Cash and equivalents, Q2 FY2024, at 2024-06-30$89.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure94.3Cash and equivalents, Q3 FY2024, at 2024-09-30$94.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure136Cash and equivalents, FY2024, at 2024-12-31$135.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076730.Report this figure110Cash and equivalents, Q1 FY2025, at 2025-03-31$110.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure73.1Cash and equivalents, Q2 FY2025, at 2025-06-30$73.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure63.7Cash and equivalents, Q3 FY2025, at 2025-09-30$63.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure93.7Cash and equivalents, FY2025, at 2025-12-31$93.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure91.4Cash and equivalents, Q1 FY2026, at 2026-03-31$91.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure46.1Cash and equivalents, Q2 FY2026, at 2026-06-30$46.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Current assets$m226Current assets, Q3 FY2023, at 2023-09-30$225.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure225Current assets, FY2023, at 2023-12-31$225.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029137.Report this figure227Current assets, Q1 FY2024, at 2024-03-31$227.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure234Current assets, Q2 FY2024, at 2024-06-30$234.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure239Current assets, Q3 FY2024, at 2024-09-30$238.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure286Current assets, FY2024, at 2024-12-31$285.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076730.Report this figure268Current assets, Q1 FY2025, at 2025-03-31$268.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure260Current assets, Q2 FY2025, at 2025-06-30$260.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure300Current assets, Q3 FY2025, at 2025-09-30$299.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure362Current assets, FY2025, at 2025-12-31$362.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure269Current assets, Q1 FY2026, at 2026-03-31$268.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure200Current assets, Q2 FY2026, at 2026-06-30$200.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Total assets$m463Total assets, Q3 FY2023, at 2023-09-30$462.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure460Total assets, FY2023, at 2023-12-31$460.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029137.Report this figure458Total assets, Q1 FY2024, at 2024-03-31$458.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure443Total assets, Q2 FY2024, at 2024-06-30$443.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure446Total assets, Q3 FY2024, at 2024-09-30$446.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure498Total assets, FY2024, at 2024-12-31$497.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076730.Report this figure467Total assets, Q1 FY2025, at 2025-03-31$467.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure461Total assets, Q2 FY2025, at 2025-06-30$461.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure510Total assets, Q3 FY2025, at 2025-09-30$509.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure599Total assets, FY2025, at 2025-12-31$598.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure520Total assets, Q1 FY2026, at 2026-03-31$520.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure406Total assets, Q2 FY2026, at 2026-06-30$406.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Current liabilities$m81.5Current liabilities, Q3 FY2023, at 2023-09-30$81.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure80.5Current liabilities, FY2023, at 2023-12-31$80.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029137.Report this figure82.8Current liabilities, Q1 FY2024, at 2024-03-31$82.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure85.7Current liabilities, Q2 FY2024, at 2024-06-30$85.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure77.3Current liabilities, Q3 FY2024, at 2024-09-30$77.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure77.5Current liabilities, FY2024, at 2024-12-31$77.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076730.Report this figure65.1Current liabilities, Q1 FY2025, at 2025-03-31$65.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure65.8Current liabilities, Q2 FY2025, at 2025-06-30$65.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure90.3Current liabilities, Q3 FY2025, at 2025-09-30$90.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure100Current liabilities, FY2025, at 2025-12-31$100.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure76.0Current liabilities, Q1 FY2026, at 2026-03-31$76.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure57.0Current liabilities, Q2 FY2026, at 2026-06-30$57.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Total liabilities$m186Total liabilities, Q3 FY2023, at 2023-09-30$185.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure181Total liabilities, FY2023, at 2023-12-31$181.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029137.Report this figure180Total liabilities, Q1 FY2024, at 2024-03-31$180.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure180Total liabilities, Q2 FY2024, at 2024-06-30$179.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure168Total liabilities, Q3 FY2024, at 2024-09-30$167.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure113Total liabilities, FY2024, at 2024-12-31$112.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076730.Report this figure99.3Total liabilities, Q1 FY2025, at 2025-03-31$99.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure99.9Total liabilities, Q2 FY2025, at 2025-06-30$99.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure124Total liabilities, Q3 FY2025, at 2025-09-30$123.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure165Total liabilities, FY2025, at 2025-12-31$164.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure139Total liabilities, Q1 FY2026, at 2026-03-31$138.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure118Total liabilities, Q2 FY2026, at 2026-06-30$118.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure
Long-term debt$m68.0Long-term debt, Q3 FY2023, at 2023-09-30$68.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure66.6Long-term debt, FY2023, at 2023-12-31$66.6m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-02-29, accession 0000950170-24-023150.Report this figure65.2Long-term debt, Q1 FY2024, at 2024-03-31$65.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure63.8Long-term debt, Q2 FY2024, at 2024-06-30$63.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure62.3Long-term debt, Q3 FY2024, at 2024-09-30$62.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m277Shareholders' equity, Q3 FY2023, at 2023-09-30$276.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure279Shareholders' equity, FY2023, at 2023-12-31$278.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076730.Report this figure278Shareholders' equity, Q1 FY2024, at 2024-03-31$278.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure264Shareholders' equity, Q2 FY2024, at 2024-06-30$263.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure279Shareholders' equity, Q3 FY2024, at 2024-09-30$278.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure263Shareholders' equity, FY2024, at 2024-12-31$262.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure243Shareholders' equity, Q1 FY2025, at 2025-03-31$242.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure233Shareholders' equity, Q2 FY2025, at 2025-06-30$233.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure255Shareholders' equity, Q3 FY2025, at 2025-09-30$255.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure300Shareholders' equity, FY2025, at 2025-12-31$300.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure245Shareholders' equity, Q1 FY2026, at 2026-03-31$244.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure148Shareholders' equity, Q2 FY2026, at 2026-06-30$148.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure

Cash flow

Operating cash flow−$31.7m, Q2 FY2026
Capital expenditure$1.1m, Q2 FY2026
Organogenesis Holdings Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m16.7Operating cash flow, Q3 FY2023, three months to 2023-09-30$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125431. Derived: 9-month figure less the 6-month figure.Report this figure10.6Operating cash flow, Q4 FY2023, three months to 2023-12-31$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(10.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure4.7Operating cash flow, Q2 FY2024, three months to 2024-06-30$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105048. Derived: 6-month figure less the 3-month figure.Report this figure8.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269697. Derived: 9-month figure less the 6-month figure.Report this figure10.9Operating cash flow, Q4 FY2024, three months to 2024-12-31$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure(19.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$19.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(32.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$32.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338049. Derived: 6-month figure less the 3-month figure.Report this figure3.1Operating cash flow, Q3 FY2025, three months to 2025-09-30$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269697. Derived: 9-month figure less the 6-month figure.Report this figure39.4Operating cash flow, Q4 FY2025, three months to 2025-12-31$39.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure21.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure(31.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$31.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338049. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m6.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$6.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125431. Derived: 9-month figure less the 6-month figure.Report this figure3.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$3.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure2.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure1.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105048. Derived: 6-month figure less the 3-month figure.Report this figure2.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269697. Derived: 9-month figure less the 6-month figure.Report this figure3.4Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure3.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure3.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338049. Derived: 6-month figure less the 3-month figure.Report this figure2.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269697. Derived: 9-month figure less the 6-month figure.Report this figure4.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076730. Derived: 12-month figure less the 9-month figure.Report this figure3.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure1.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338049. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)128.67m, Q2 FY2026
Organogenesis Holdings Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares132Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30132,232,954 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062056.Report this figure131Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31131,083,841 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-057050.Report this figure133Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30133,066,010 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094009.Report this figure133Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30133,417,721 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125431.Report this figure132Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31131,861,772 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066962.Report this figure133Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30132,573,153 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105048.Report this figure134Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30133,926,755 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure126Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31126,295,642 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure127Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30126,853,536 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure131Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30130,848,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269697.Report this figure128Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31127,797,013 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001661181-26-000008.Report this figure129Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30128,674,548 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure

Shares outstanding: 128.67mShares outstanding, period not labelled, at 2026-07-31128,674,548 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338049.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.